Assessment of cognitive impairments and seizure characteristics in electroconvulsive therapy with and without sodium valproate in manic patients

Neuropsychobiology

Volumn 67, Issue 1, 2013, Pages 14-24

  Haghighi, Mohammad ^a   Bajoghli, Hafez ^b   Bigdelou, Gholamreza ^a   Jahangard, Leila ^a   Holsboer Trachsler, Edith ^c   Brand, Serge ^c  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cognitive impairments; Double blind randomized clinical trial; Electroconvulsive therapy; Manic episode; Seizure characteristics; Sodium valproate

Indexed keywords

BENZODIAZEPINE DERIVATIVE; GLUCOSE; NEUROLEPTIC AGENT; PLACEBO; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; MANIA; MEDICAL DOCUMENTATION; MENTAL PATIENT; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL; SEIZURE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; BIPOLAR DISORDER; COGNITION DISORDERS; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; SEIZURES; VALPROIC ACID;

EID: 84870349500     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000343490     Document Type: Article

References (39)

1. Merikangas KR, Akiskal HS, Angst J, et al: Life time and 12-month prevalence of bipolar spectrum disorder in the National Comor-bidity Survey replication. Arch Gen Psychiatry 2007; 64: 543-552.
2. Holtmann M, Duketis E, Poustka L, et al: Bipolar disorder in children and adolescents in Germany: national trends in the rates of in-patients, 2000-2007. Bipolar Disord 2010; 12: 155-163.
3. Duffy A: The early natural history of bipolar disorder: what we have learned from longitudinal high-risk research. Can J Psychiatry 2010; 55: 477-485.
4. Sadock BJ, Sadock VA: Kaplan and Sadock's Synapsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Philadelphia, Lippincott Williams & Wilkins, 2007.
5. American Psychiatric Association Committee on Electroconvulsive Therapy: The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging, ed 2. Washington, American Psychiatric Association, 2001.
6. Versiani M, Cheniaux E, Landeira-Fernan-dez J: Efficacy and safety of electoconvulsive therapy in the treatment of bipolar disorder. J ECT 2011; 27: 153-164.
7. Sienaert P: What we have learned about elec-troconvulsive therapy and its relevance for the practicing psychiatrist. Can J Psychiatry 2011; 56: 5-12.
8. Abrams R: Electroconvulsive Therapy, ed 4. New York, Oxford University Press, 2002, pp 17-42.
9. National Institutes of Health: Electrocon-vulsive Therapy. NIH Consensus Statement Online. Bethesda, National Institutes of Health, 1985. http://text.nlm.nih.gov/nih/cdc/www/51.html (accessed November 2, 2011).
10. Reisner AD: The electroconvulsive therapy controversy: evidence and ethics. Neuropsy-chol Rev 2003; 13: 199-219.
11. Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association. Am J Psychiatry 1994; 151(12 suppl):1-36.
12. Payne NA, Prudic J: Electroconvulsive therapy. 1. A perspective on the evolution and current practice of ECT. J Psychiatr Pract 2009; 15: 346-368.
13. De la Serna E, Flamarique I, Castro-For-nieles J, et al: Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with elec-troconvulsive therapy. J Child Adolesc Psy-chopharmacol 2011; 21: 611-619.
14. Cohen D, Taleb O, Flament M, et al: Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry 2010; 157: 460-462.
15. Ghaziuddin N, Laughrin D, Giordani B: Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psy-chopharmacol 2000; 10: 269-276.
16. Rami L, Goti X, Ferrer J, et al: Cognitive functions after only one ECT session: a controlled study. Psychiatry Res 2008; 158: 389-394.
17. Russell JC, Rasmussen KG, O'Connor MK, et al: Long-term maintenance ECT: a retrospective review of ef ficacy and cognitive outcome. J ECT 2009; 19: 4-9.
18. Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J: Randomized comparison of ultra-brief and unilateral electroconvulsive therapy for major depression: cognitive side-effects. J Affect Disord 2010; 122: 60-67.
19. Meeter M, Murre JMJ, Janssen SMJ, et al: Retrograde amnesia after electroconvulsive therapy: a temporary effect? J Affect Disord 2011; 132: 216-222.
20. Warnell RL, Swartz CM, Thomson A: Clinically insubstantial cognitive side effects of bitemporal electroconvulsive therapy at 0.5 msec pulse width. Ann Clin Psychiatry 2011; 23: 257-262.
21. MacQueen G, Parkin C, Marriott M, et al: The long-term impact of treatment with electroconvulsive therapy on discrete memory systems in patients with bipolar disorder. J Psychiatry Neurosci 2007; 32: 241-249.
22. Roberts MA, Attah JR: Carbamazepine and ECT. Br J Psychiatry 1988; 53: 418.
23. Sienaert P, Bouckaert F, Milo W, Peuskens J: Electroconvulsive therapy in Belgium. A questionnaire study on the practice of elec-troconvulsive therapy in Flanders and the Brussels Capital Region. J ECT 2005: 21: 3-6.
24. Virupaksha HS, Shashidhara B, Thirthalli J, et al: Comparison of electroconvulsive therapy (ECT) with or without anti-epileptic drugs in bipolar disordered. J Affect Disord 2010; 127: 66-70.
25. Scott AIF: The ECT Handbook. (Third Report of the Royal College of Psychiatrists' Special Committee on ECT). Council Report CR128. London, The Royal College of Psychiatrists, 2005.
26. Sienaert P, Peuskens J: Anticonvulsants during electroconvulsive therapy: review and recommendations. J ECT 2007; 23: 120-123.
27. Jahangard L, Haghighi M, Bigdelou G, et al: Comparing efficacy of ECT with and without concurrent sodium valproate therapy in manic patients. J ECT 2012; 28: 118-123.
28. Penland HR, Ostroff RB: Combined use of lamotrigine and electroconvulsive therapy in bipolar depression: a case series. J ECT 2006; 22: 142-147.
29. Sienaert P, Roelens Y, Demunter H, et al: Concurrent use of lamotrigine and electro-convulsive therapy. J ECT 2011; 27: 148-152.
30. Zarate CA, Tohen M, Baraibar G: Combined valproate or carbamazepine and electrocon-vulsive therapy. Ann Clin Psychiatry 1997; 9: 19-25.
31. http://www.consort-statement.org/consort-statement/flow-diagram0/ (accessed November 14, 2011).
32. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 2000.
33. Barekatain M, Jahangard L, Haghighi M, et al: Bifrontal versus bitemporal electrocon-vulsive therapy in severe manic patients. J ECT 2008; 24: 199-202.
34. Zschocke S: Klinische Elekroenzephalogra-phie. Heidelberg, Springer, 2002.
35. Guy W (ed): ECDEU Assessment for Psycho-pharmacology, Revised Edition. Rockville, NIMH Publication, 1976.
36. Folstein M, Folstein S, McHugh PR: Minimental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
37. Cohen J: Statistical Power Analysis for the Behavioural Sciences, ed 2. Hillsdale, Erlbaum, 1988.
38. Peterchev AV, Rosa MA, Deng Z-D, et al: Electroconvulsive therapy stimulus parameters. Rethinking dosage. J ECT 2010; 26: 159-174.
39. von Helversen B, Wilke A, Johnson T, et al: Performance benefits of depression: sequential decision making in a healthy sample and a clinically depressed sample. J Abnorm Psy-chol 2011; 120: 962-968.